A randomized double‐blind placebo‐controlled study with subcutaneous recombinant human erythropoietin in patients with low‐risk myelodysplastic syndromes

Ferrini, P R ; Grossi, A ; Vannucchi, A M ; Barosi, G ; Guarnone, R ; Piva, N ; Musto, P ; Balleari, E

British journal of haematology, 1998-12, Vol.103 (4), p.1070-1074 [Periódico revisado por pares]

Oxford, U.K. and Cambridge, USA: Blackwell Science Ltd

Texto completo disponível